Spaceflight neuro-ocular syndrome (SANS) poses the second-most serious risk to human health during extended spaceflight missions. Understanding how it occurs and may be prevented is crucial in the planning of exploration space missions such as travel to Mars. Evidence for various mechanisms by which SANS develops and might be treated or mitigated will be presented.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- Community Eye Care Professionals
- Ophthalmologists
- Optometrists
- Fellows
- Residents
- Medical students
- Graduate students
- Postdoctoral Fellows
- Vision Scientists
At the end of this session, I will be able to:
- Recognize ocular changes that occur with long-duration spaceflight.
- Evaluate possible pathogenic mechanisms.
- Determine strategies to mitigate the risk through countermeasures.
All persons in control of content has no relevant financial relationships to disclose with the exception of:
Name | Company | Role |
---|---|---|
Prem Subramanian, MD | GenSight Biologics | Investigator |
Santhera Pharmaceuticals | Investigator | |
Quark Pharmaceuticals | Investigator |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.